
X
AI startup Nucleai has immuno-oncology treatment failures in its sights
https://pharmaphorum.com/news/ai-startup-nucleai-has-immuno-oncology-treatment-failures-in-its-sights/
Microbiome Movement – Drug Development Europe Summit
Mike Page, invite to Orphan Drugs & Rare Diseases
Grail, the US-based cancer detection startup backed by billionaires Jeff Bezos and Bill Gates is reportedly mulling a launch on the Hong Kong stock exchange.
For the first time, FDA approves drug on the basis of biomarkers, rather than location.
What has been its impact on the pharma and healthcare sectors?